Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 19/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21552840 | 0.97 | KDM1A (0.46) | KDM1A | |
| SCHEMBL21553142 | 0.92 | KDM1A (0.47) | KDM1A | |
| SCHEMBL21552871 | 0.91 | KDM1A (0.43) | KDM1A | |
| SCHEMBL26032167 | 0.90 | KDM1A (0.43) | KDM1A | |
| SCHEMBL21553118 | 0.90 | KDM1A (0.45) | KDM1A | |
| SCHEMBL21553009 | 0.87 | KDM1A (0.45) | KDM1A | |
| SCHEMBL21553133 | 0.85 | KDM1A (0.43) | KDM1A | |
| SCHEMBL21552852 | 0.85 | KDM1A (0.46) | KDM1A | |
| SCHEMBL21564618 | 0.84 | KDM1A (0.43) | KDM1A | |
| SCHEMBL21553168 | 0.83 | KDM1A (0.43) | KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230250090-A1 | KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE | IMAGO BIOSCIENCES INC (US) | 2023-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230250090-A1 | KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE | KDM1B, KDM1A, KDM2A | KDM1A 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.